The global neuroscience market reached a valuation of USD 35.9 billion in 2024 and is projected to grow to USD 48.0 billion by 2033, reflecting a steady CAGR of 3.1% during 2025–2033. This growth is fueled by increasing neurological disorder prevalence, technological advancements in neuroimaging, and rising investments in research and development. Additionally, growing awareness of mental health issues, expanding applications in neuroinformatics and neuroprosthetics, and supportive government policies are contributing to market expansion.
Study Assumption Years
- Base Year: 2024
- Historical Years: 2019–2024
- Forecast Years: 2025–2033
Neuroscience Market Key Takeaways
- Market Size & Growth: Valued at USD 35.9 billion in 2024, the market is expected to reach USD 48.0 billion by 2033, growing at a CAGR of 3.1% during the forecast period.
- Technological Advancements: Innovations in neuroimaging tools and the integration of AI and machine learning are enhancing diagnostics and personalized treatments.
- Rising Neurological Disorders: An increasing prevalence of conditions like epilepsy and Alzheimer’s disease is driving demand for neuroscience research and therapies.
- Government Support: Supportive policies and funding initiatives are bolstering research and development activities in neuroscience.
- Aging Population: The growing elderly demographic is contributing to higher incidences of neurological ailments, necessitating advanced treatment options.
Market Growth Factors
- Advancements in Technology
Advancements in technology are significantly driving the growth of the neuroscience market by accelerating research and improving diagnostic accuracy. Key innovations include artificial intelligence (AI) and machine learning (ML), which enhance data analysis for conditions like Alzheimer’s and Parkinson’s, enabling personalized treatment and accelerating drug discovery. Advanced neuroimaging techniques, such as high-resolution fMRI and connectomics, offer deeper insights into brain function and structure. Brain-computer interfaces (BCIs) provide crucial applications in assistive technology, allowing paralyzed individuals to interact with external devices. Additionally, genomic and proteomic studies are facilitating biomarker discovery for neurological diseases, while digital health solutions are enhancing remote monitoring and management, thus making neurological care more accessible. The combination of these advancements is expanding the market into new areas of consumer health and rehabilitation.
- Increasing Prevalence of Neurological Disorders
The neuroscience market is rapidly expanding due to the increasing prevalence of neurological disorders, such as Alzheimer’s and Parkinson’s, alongside an aging global population. As life expectancy rises, the incidence of neurodegenerative diseases grows, driving demand for advanced diagnostics and innovative therapies. Technological advancements, including AI-powered imaging systems and new treatment devices, further fuel this growth. Increased research and development investments from pharmaceutical companies and research institutions boost exploration into brain functions, creating more effective solutions. Additionally, heightened awareness and advocacy from patients and healthcare professionals promote the necessity for advanced diagnostic tools. Areas experiencing significant growth include advanced diagnostics, therapeutics focused on novel drugs, neuroscience instruments, and research consumables, collectively contributing to the market’s dynamic expansion.
- Growth of Neuromodulation Techniques
Neuromodulation techniques are becoming key players in the neuroscience market, thanks to advancements in technology, a rise in neurological disorders, and a growing demand for non-drug treatments. These therapies have expanded their reach, now covering everything from pain management with Spinal Cord Stimulation (SCS) to neurological issues like Parkinson’s through Deep Brain Stimulation (DBS), and even psychiatric conditions such as depression with Transcranial Magnetic Stimulation (TMS). The growth in this area is fueled by innovations like smaller devices, adaptive systems that personalize therapy, and the integration of AI with neuroimaging for precise targeting. Additionally, an aging population and heightened public awareness are driving more patients to seek out non-pharmaceutical alternatives. This all takes place in a favorable economic and regulatory environment, marked by increased investment in research and development and quicker approval processes, which together are pushing the neuroscience market ahead.
Request for a sample copy of this report:
https://www.imarcgroup.com/neuroscience-market/requestsample
Market Segmentation
By Component
- Instruments and Consumables: Includes devices and materials used in neuroscience research and diagnostics.
- Software and Services: Comprises analytical tools and support services facilitating neuroscience studies.
By Technology
- Brain Imaging: Techniques like MRI and PET scans used for visualizing brain structures and functions.
- Neuro-Microscopy: Microscopic methods for examining neural tissues at cellular levels.
- Electrophysiology: Studies electrical properties of biological cells and tissues in the nervous system.
- Neuroproteomic Analysis: Analyzes protein expressions and functions in neural contexts.
- Animal Behaviour Analysis: Observes and interprets behavioral patterns in animal models for neurological studies.
- Others: Encompasses additional emerging technologies in neuroscience research.
By End User
- Hospitals: Healthcare institutions providing diagnostic and therapeutic services for neurological conditions.
- Diagnostic Laboratories: Facilities specializing in testing and analysis of neurological samples.
- Research and Academic Institutes: Organizations conducting neuroscience research and education.
- Others: Includes other entities involved in neuroscience applications.
By Region
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Regional Insights
North America leads the neuroscience market, driven by advanced healthcare infrastructure, significant investments in research and development, and the presence of key industry players. The region’s focus on technological innovation and early adoption of advanced diagnostic tools contributes to its dominant position in the global market.
Recent Developments & News
In January 2025, the President of India inaugurated advanced facilities at the National Institute of Mental Health and Neurosciences (NIMHANS) in Bengaluru, including an AI-enabled 3T MRI scanner, enhancing diagnostic capabilities in mental health. Additionally, in December 2024, Medtronic launched the FDA-approved Percept RC neurostimulator in India, designed for deep brain stimulation in patients with movement disorders like Parkinson’s and epilepsy. This innovative device features integrated sensing and a long-lasting rechargeable battery, aiming to provide personalized treatments and improve patient outcomes in neurological care.
Key Players
Alpha Omega Engineering, Biobserve GmbH, Blackrock Neurotech, Doric Lenses Inc., General Electric Company, Kernel, Laserglow Technologies, Mightex Systems, NeuroNexus Technologies Inc., Noldus Information Technology B.V., Plexon Inc., Prizmatix Ltd., Siemens AG, etc.
Ask Analyst for Customization:
https://www.imarcgroup.com/request?type=report&id=5133&flag=C
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include a thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape, and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: (+1-201971-6302)
